Episode 27: Early Speech and Language Development of Children
How can you tell the difference between a child who may have a speech or language disorder and a “late bloomer?” What are the benefits of early intervention? Speech-language pathologist and ASHA fellow Elizabeth Crais answers these and other key questions as part of ASHA’s “Identify the Signs” campaign.
Read the Episode 27 transcript (Source: ASHA Podcast)
Source: ASHA Podcast - September 16, 2013 Category: Speech Therapy Authors: webmaster at asha.org (American Speech-Language-Hearing Assocation)ASHA Tags: Schools Speech-Language Pathology Source Type: podcasts
CIGNA Restricts Coverage of Genetic Testing
Dr. Kathy Miller reports on the potential harm that may come as a result of CIGNA's new policy that no genetic testing will be covered unless the patient first sees a genetic counselor. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - September 16, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
CIGNA Restricts Coverage of Genetic Testing
Dr. Kathy Miller reports on the potential harm that may come as a result of CIGNA ' s new policy that no genetic testing will be covered unless the patient first sees a genetic counselor. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - September 16, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
'Do As I Do: Take Aspirin Daily ’
The evidence for the benefits of low-dose aspirin in primary and secondary prevention of colorectal cancer is so compelling that it has convinced CRC specialist Dr. David Kerr to take 100 mg daily. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 30, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Cancer? Not!
What's in a word? Enough to 'set your hair on fire' if the word is cancer, says Dr. George Lundberg, who comments on the importance of not calling a lesion 'cancer' when it is not. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 29, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Sofusburvir/ribavirin for HCV, cholangiography during cholecystectomy, clinical diagnosis of rotator cuff pathology, and more.
Editor's Audio Summary by Edward H. Livingston, MD, Deputy Editor, the Journal of the American Medical Association, for the August 28, 2013 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - August 27, 2013 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
The silent misdiagnosis
This week, Al Mulley, Dartmouth Center for Health Care Delivery Science, and Tessa Richards, BMJ associate editor, discuss the silent misdiagnosis: that of patient preferences.
Removing pre-cancerous cells spotted through screening is the foremost defence against cervical cancer. However, a recent BMJ paper has shown that women who go through this have a fourfold risk of going on to develop cancer compared to women who’ve only ever had normal smears, even if they complete follow up and are given the all clear. Matejka Rebolj, postdoctoral researcher, Department of Public Health, University of Copenhagen, and Chris Meijer...
Source: The BMJ Podcast - August 27, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Can We Identify Risk for Drug Toxicity?
Drawing on recent developments, Dr. David Kerr suggests that DNA technology could identify markers that correlate with the risk of developing serious cancer drug side effects. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 26, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
'Would You Sell Your Soul for $10?'
Dr. Bruce Cheson forecasts that the Sunshine Act, requiring physicians to disclose most payment and gifts from industry over $10, will bring showers of misinterpretation and could hinder research. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 26, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
New Tool Cracks the 'Old Chestnut' of Tumor Response
Dr. David Kerr discusses time to tumor growth, a metric that outscored all other means of characterizing tumor response rate and correlated with overall survival in patients with colorectal cancer. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 19, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Mok and Scagliotti: What You Need to Know About Afatinib
A Skype conversation between Drs. Tony Mok and Giorgio Scagliotti details the efficacy and potential toxicities of afatinib, which is newly approved by the FDA for EGFR-positive lung cancer patients. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - July 12, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
